PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer
BackgroundThe aim of this study was to evaluate the clinical usefulness of radiomics signature-derived 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) for the early prediction of neoadjuvant chemotherapy (NAC) outcomes in patients with (BC).MethodsA total o...
Main Authors: | Liping Yang, Jianfei Chang, Xitao He, Mengye Peng, Ying Zhang, Tingting Wu, Panpan Xu, Wenjie Chu, Chao Gao, Shaodong Cao, Shi Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.849626/full |
Similar Items
-
Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with <sup>18</sup>F-FDG PET Radiomics Based Machine Learning Classification
by: Roelof J. Beukinga, et al.
Published: (2022-04-01) -
Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
by: Sun-pyo Hong, et al.
Published: (2024-10-01) -
18F-FDG PET/CT-based radiomics nomogram could predict bone marrow involvement in pediatric neuroblastoma
by: Lijuan Feng, et al.
Published: (2022-09-01) -
Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer
by: N. G. Chanchikova, et al.
Published: (2021-01-01) -
PET/CT: Current status in India
by: Venkatesh Rangarajan, et al.
Published: (2008-10-01)